The 13 drugs most likely to be chosen for CMS negotiations, according to the study: Ozempic, Rybelsus and Wegovy (semaglutide): Novo Nordisk's treatment for Type 2 diabetes and weight management.
Shares of Wanbury locked in 5 per cent upper circuit on the BSE in Thursday’s intraday trade. By comparison, the BSE Sensex was trading 0.25 per cent higher at 81,730 levels at around 12:22 PM IST.